Previous Article | Next Article ![]()
Journal of Bacteriology, February 2005, p. 854-861, Vol. 187, No. 3
0021-9193/05/$08.00+0 doi:10.1128/JB.187.3.854-861.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Natalie J. Garton,2,
,
Jérôme Nigou,1
Thérèse Brando,1
Germain Puzo,1 and
Iain C. Sutcliffe2*
Institut de Pharmacologie et de Biologie Structurale du Centre National de la Recherche Scientifique, Toulouse, France,1 Institute of Pharmacy, Chemistry and Biomedical Sciences, The University of Sunderland, Sunderland, United Kingdom2
Received 1 September 2004/ Accepted 22 October 2004
Lipoarabinomannan (LAM) lipoglycans have been characterized from a range of mycolic acid-containing actinomycetes and from the amycolate actinomycete Amycolatopsis sulphurea. To further understand the structural diversity of this family, we have characterized the lipoglycan of the otic commensal Turicella otitidis. T. otitidis LAM (TotLAM) has been determined to consist of a mannosyl phosphatidylinositol anchor unit carrying an (
1
6)-linked mannan core and substituted with terminal-arabinosyl branches. Thus, TotLAM has a novel truncated LAM structure. Using the human monocytic THP-1 cell line, it was found that TotLAM exhibited only minimal ability to induce tumor necrosis factor alpha. These findings contribute further to our understanding of actinomycete LAM diversity and allow further speculation as to the correlation between LAM structure and the immunomodulatory activities of these lipoglycans.
M.G. and N.J.G. contributed equally to this study.
Present address: Department of Infection, Immunity and Inflammation, Leicester University, Leicester LE1 9HN, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»